Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.63 |
| ▸ | BRD2 | P25440 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.35 |
| ▸ | MEN1 | O00255 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylpyrrolidone SCHEMBL3795268 | 0.90 | BRD4 (0.71) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL3802011 | 0.90 | BRD4 (0.77) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL7705049 | 0.90 | BRD4 (0.77) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL9815876 | 0.88 | BRD4 (0.74) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL4881818 | 0.87 | BRD4 (0.65) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL4926217 | 0.83 | BRD4 (0.44) | BRD4BRD2LMNAKMT2ASMN1; SMN2 | |
| Methylpyrrolidone SCHEMBL7117712 | 0.82 | BRD4 (0.71) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL28152522 | 0.82 | BRD4 (0.71) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL27843521 | 0.82 | BRD4 (0.77) | BRD4BRD2LMNAPIK3CDKMT2A | |
| Methylpyrrolidone SCHEMBL1841013 | 0.82 | BRD4 (0.77) | BRD4BRD2LMNAPIK3CDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720420-A1 | INJECTABLE LONG-ACTING LOCAL ANESTHETIC SEMI-SOLID GEL FORMULATIONS | Huzhou Hui Zhong Ji Shi Biotechnology Co., Ltd. (CN) | 2020-10-14 | — | — | EP | disclosed |
| US-10561606-B2 | Injectable long-acting local anesthetic semi-solid gel formulations | MIRA PHARMA CORPORATION (US) | 2020-02-18 | — | — | US | disclosed |
| WO-2019113366-A1 | INJECTABLE LONG-ACTING LOCAL ANESTHETIC SEMI-SOLID GEL FORMULATIONS | MIRA PHARMA CORPORATION (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20190167574-A1 | INJECTABLE LONG-ACTING LOCAL ANESTHETIC SEMI-SOLID GEL FORMULATIONS | HUZHOU HUI ZHONG JI SHI BIOTECHNOLOGY CO., LTD (CN) | 2019-06-06 | — | — | US | disclosed |
| US-9445992-B2 | Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion | ARISGEN SA (CH) | 2016-09-20 | — | — | US | disclosed |
| EP-2007509-B1 | DISPERSION OF NANO-ALUMINA IN A RESIN OR SOLVENT SYSTEM | ALTANA ELEC INSULATION GMBH (DE) | 2015-04-29 | — | — | EP | disclosed |
| US-20120302502-A1 | MUCOSAL DELIVERY COMPOSITIONS COMPRISING A PEPTIDE COMPLEXED WITH A CROWN COMPOUND AND/OR A COUNTER ION | ARISGEN SA (CH) | 2012-11-29 | — | — | US | disclosed |
| EP-2504019-A2 | MUCOSAL DELIVERY COMPOSITION COMPRISING A PEPTIDE COMPLEXED WITH A CROWN COMPOUND AND/OR A COUNTER ION | ArisGen SA (CH) | 2012-10-03 | — | — | EP | disclosed |
| WO-2011064316-A2 | MUCOSAL DELIVERY OF PEPTIDES | BOTTI PAOLO (CH) | 2011-06-03 | — | — | WO | disclosed |
| US-20030215571-A1 | Composition containing a polymer or copolymer of a 3,4-dialkoxythiophene and non-aqueous solvent | AGFA-GEVAERT (BE) | 2003-11-20 | — | — | US | disclosed |
| WO-2003086348-A1 | ALLERGIC DERMATITIS FORMULATION AND METHOD OF TREATMENT | DERMCARE-VET PTY LTD (AU) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302502-A1 | MUCOSAL DELIVERY COMPOSITIONS COMPRISING A PEPTIDE COMPLEXED WITH A CROWN COMPOUND AND/OR A COUNTER ION | VIP, CFTR, IAPP | BRD4 3207/4885BRD2 2320/4885LMNA 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.